DUBLIN, Ohio — Cardinal Health Inc. has closed its $1.115 billion acquisition of pharmaceutical distributor Harvard Drug Group. Cardinal said Monday that the all-cash deal, announced in early June, will boost its generic drug distribution business as well as expand its over-the counter drug product offerings and its telesales programs and capabilities. Harvard Drug also
DUBLIN, Ohio — Cardinal Health Inc. plans to acquire pharmaceutical distributor The Harvard Drug Group (THDG) from private equity firm Court Square Capital Partners for $1.12 billion. Based in Livonia, Mich., THDG is a distributor of generic drugs, over-the-counter medicines and related products to retail, institutional and alternate care customers. THDG had revenue of about
DUBLIN, Ohio — Cardinal Health Inc. plans to acquire pharmaceutical distributor The Harvard Drug Group (THDG) from private equity firm Court Square Capital Partners for $1.115 billion. Cardinal said Friday that it will use cash and new debt to finance the transaction, which is expected to close in the beginning of its 2016 fiscal year,
